BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20663905)

  • 1. The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage.
    Mao FJ; Sidorova JM; Lauper JM; Emond MJ; Monnat RJ
    Cancer Res; 2010 Aug; 70(16):6548-55. PubMed ID: 20663905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Werner protein protects nonproliferating cells from oxidative DNA damage.
    Szekely AM; Bleichert F; Nümann A; Van Komen S; Manasanch E; Ben Nasr A; Canaan A; Weissman SM
    Mol Cell Biol; 2005 Dec; 25(23):10492-506. PubMed ID: 16287861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Werner's syndrome protein is required for correct recovery after replication arrest and DNA damage induced in S-phase of cell cycle.
    Pichierri P; Franchitto A; Mosesso P; Palitti F
    Mol Biol Cell; 2001 Aug; 12(8):2412-21. PubMed ID: 11514625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Werner helicase mediates the senescence and cell cycle of leukemia cells by regulating DNA repair pathways.
    Cui X; Hou J; Wang S; Yu J; Cheng S; Yu L; Song FJ; Luo H
    Int J Biol Macromol; 2024 Jan; 255():128305. PubMed ID: 37992942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RecQ dysfunction contributes to social and depressive-like behavior and affects aldolase activity in mice.
    Hou Y; Park JH; Dan X; Chu X; Yang B; Hussain M; Croteau DL; Bohr VA
    Neurobiol Dis; 2023 May; 180():106092. PubMed ID: 36948261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR.
    Zong D; Koussa NC; Cornwell JA; Pankajam AV; Kruhlak MJ; Wong N; Chari R; Cappell SD; Nussenzweig A
    Genes Dev; 2023 Oct; 37(19-20):913-928. PubMed ID: 37932011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of quinazolin-4-one derivatives as potential anticancer agents and investigation of their interaction with RecQ helicases.
    Haggag HS; Aboukhatwa SM; Nafie MS; Paul A; Sharafeldin N; Oliver AW; El-Hamamsy MH
    Bioorg Chem; 2024 Mar; 144():107086. PubMed ID: 38219478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer.
    Hao S; Tong J; Jha A; Risnik D; Lizardo D; Lu X; Goel A; Opresko PL; Yu J; Zhang L
    Proc Natl Acad Sci U S A; 2022 Dec; 119(51):e2211775119. PubMed ID: 36508676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.
    Panier S; Maric M; Hewitt G; Mason-Osann E; Gali H; Dai A; Labadorf A; Guervilly JH; Ruis P; Segura-Bayona S; Belan O; Marzec P; Gaillard PL; Flynn RL; Boulton SJ
    Mol Cell; 2019 Oct; 76(1):27-43.e11. PubMed ID: 31447390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers.
    Ferretti S; Hamon J; de Kanter R; Scheufler C; Andraos-Rey R; Barbe S; Bechter E; Blank J; Bordas V; Dammassa E; Decker A; Di Nanni N; Dourdoigne M; Gavioli E; Hattenberger M; Heuser A; Hemmerlin C; Hinrichs J; Kerr G; Laborde L; Jaco I; Núñez EJ; Martus HJ; Quadt C; Reschke M; Romanet V; Schaeffer F; Schoepfer J; Schrapp M; Strang R; Voshol H; Wartmann M; Welly S; Zécri F; Hofmann F; Möbitz H; Cortés-Cros M
    Nature; 2024 May; 629(8011):443-449. PubMed ID: 38658754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisbenzylisoquinoline alkaloid fangchinoline derivative HY-2 inhibits breast cancer cells by suppressing BLM DNA helicase.
    Zhang W; Yu X; Bao L; He T; Pan W; Li P; Liu J; Liu X; Yang L; Liu J
    Biomed Pharmacother; 2023 Dec; 169():115908. PubMed ID: 37988849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and antitumor activity of 2-substituted quinazoline-4-amine derivatives.
    Wang M; Yu J; Huang X; Yu G; Liang Q; Cheng S; Meng X; Xu G; Li H; Luo H; Xu B
    Bioorg Med Chem; 2024 Mar; 102():117660. PubMed ID: 38442524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ATP-binding site of WRN Helicase: Identification of novel inhibitors through pocket analysis and Molecular Dynamics-Enhanced virtual screening.
    Yuan H; Liu RD; Gao ZY; Zhong LT; Zhou YC; Tan JH; Huang ZS; Li Z; Chen SB
    Bioorg Med Chem Lett; 2024 May; 104():129711. PubMed ID: 38521175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules that disrupt RAD54-BLM interaction hamper tumor proliferation in colon cancer chemoresistance models.
    Kaur E; Agrawal R; Arun R; Madhavan V; Srivastava V; Kumar D; Rath PP; Kumar N; Vedagopuram S; Pandey N; Priya S; Legembre P; Gourinath S; Bajaj A; Sengupta S
    J Clin Invest; 2024 Feb; 134(8):. PubMed ID: 38421735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BLM mutation is associated with increased tumor mutation burden and improved survival after immunotherapy across multiple cancers.
    Shi H; Gao L; Yin H; Jiang M
    Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38124443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive mapping of cell fates in microsatellite unstable cancer cells support dual targe6ng of WRN and ATR.
    Zong D; Koussa NC; Cornwell JA; Pankajam AV; Kruhlak MJ; Wong N; Chari R; Cappell SD; Nussenzweig A
    bioRxiv; 2023 Jul; ():. PubMed ID: 37662356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WRN inhibitors squeeze cancer cell vulnerability.
    Kingwell K
    Nat Rev Drug Discov; 2024 May; ():. PubMed ID: 38720007
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA2 drives processing and restart of reversed replication forks in human cells.
    Thangavel S; Berti M; Levikova M; Pinto C; Gomathinayagam S; Vujanovic M; Zellweger R; Moore H; Lee EH; Hendrickson EA; Cejka P; Stewart S; Lopes M; Vindigni A
    J Cell Biol; 2015 Mar; 208(5):545-62. PubMed ID: 25733713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein degradation pathways regulate the functions of helicases in the DNA damage response and maintenance of genomic stability.
    Sommers JA; Suhasini AN; Brosh RM
    Biomolecules; 2015 Apr; 5(2):590-616. PubMed ID: 25906194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers.
    Futami K; Furuichi Y
    Front Genet; 2014; 5():441. PubMed ID: 25620975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.